AngioDynamics International

The new distribution arrangement between Minimax Medical and Angiodynamics International becomes effective from 15 November 2022. The partnership will include the distribution of Minimax Medical’s leading radio frequency ablation system for tumors/nodules on an international level.

(Above photo comes from Angiodynamics International’s post on Linked In)

AngioDynamics, a Nasdaq-listed company founded in 1988, is a leading provider of minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. The global company has over 1,200 employees operating at facilities in the United States, Europe, Asia and Latin America, and currently reaches more than 50 markets via direct sales and distributors.

Minimax Medical has been Angiodynamics Rita series products’ general distributor on China market for many years, both parties have gained mutual understanding and confidence in each other through this cooperation. Now both are very excited to commence the new partnership, and to work collaboratively to achieve ambitious growth goals and improve patient healthcare outcomes.

“I am delighted that this new partnership has come together in order to provide a greater range of solutions to clinicians and their patients. Working together with Minimax Medical will only enhance AngioDynamics International’s portfolio of treatment options, allowing us to assist the healthcare sector in improving patient lives across the globe” said Laura Piccinini, AngioDynamics Senior Vice President/General Manager – International.

Anna Li, Minimax Medical’s President, said “Minimax and Angiodynamics have been partners for more than 18 years in tumor ablation market, this new strategic cooperation has strengthened this partnership, I believe together we will be stronger and we shall prevail.”